Intravenous heparin or low-molecular weight heparin in patients with acute myocardial infarction treated with thrombolytic therapy

Intravenous heparin or low-molecular weight heparin in patients with acute myocardial infarction treated with thrombolytic therapy is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please log in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics: